Precigen, INC Form 4 insider transactions

Phil Tennant, Precigen's Chief Commercial Officer, has been granted 125,000 Restricted Stock Units, aligning his interests with shareholder value through a multi-year vesting schedule.

Precigen, Inc. Chief Operating Officer Rutul R. Shah was granted 180,000 restricted stock units (RSUs) as part of his compensation.

Donald P. Lehr, Chief Legal Officer of Precigen, Inc., was granted 125,000 restricted stock units (RSUs) on June 26, 2025, as part of his compensation.

Precigen, Inc. CEO and Director Helen Sabzevari was granted 500,000 restricted stock units, which will vest over approximately three years starting May 23, 2026.

Precigen, Inc.'s Chief Financial Officer, Harry Thomasian Jr., was granted 175,000 Restricted Stock Units, which will vest over a period starting May 23, 2026.

Precigen's Chief Financial Officer, Harry Thomasian Jr., was granted 350,000 stock options with an exercise price of $1.37, vesting over four years.

Precigen, Inc.'s Chief Legal Officer, Donald P. Lehr, was granted 250,000 stock options with an exercise price of $1.37, vesting over a four-year period.

Precigen, Inc.'s Chief Operating Officer, Rutul R. Shah, was granted 360,000 options to purchase common stock with an exercise price of $1.37, vesting over a four-year period.

Precigen, Inc.'s Chief Commercial Officer, Phil Tennant, was granted 250,000 stock options with an exercise price of $1.37, vesting over a four-year period.

PRECIGEN, Inc.'s President and CEO, Helen Sabzevari, was granted 1 million stock options with an exercise price of $1.37, vesting over four years.

Rutul R. Shah, Chief Operating Officer of Precigen, Inc., reports the acquisition and disposal of common stock and restricted stock units on May 16, 2025, to satisfy tax obligations.

Chief Commercial Officer Phil Tennant reports the vesting and subsequent disposal of Precigen, Inc. stock to cover tax obligations.

Donald P. Lehr, Chief Legal Officer of Precigen, Inc., reports the vesting and subsequent tax withholding of shares related to restricted stock units.

Chief Financial Officer of Precigen, Harry Thomasian Jr., reports the vesting and subsequent tax withholding related to restricted stock units.

Helen Sabzevari, President and CEO of Precigen, Inc., reports the acquisition and disposal of common stock and restricted stock units on May 16, 2025.

Phil Tennant, Chief Commercial Officer of Precigen, Inc., reports acquiring 66,441 restricted stock units (RSUs) that will vest on May 16, 2025.

Rutul R. Shah, Chief Operating Officer of Precigen, Inc., reported the acquisition of 174,460 Restricted Stock Units (RSUs) on April 17, 2025, which will vest on May 16, 2025.

Donald P. Lehr, Chief Legal Officer of Precigen, Inc., reports the acquisition of 165,468 Restricted Stock Units (RSUs) on April 17, 2025, vesting fully on May 16, 2025.

Harry Thomasian Jr., CFO of Precigen, Inc., reports the acquisition of 154,475 restricted stock units (RSUs) on April 17, 2025, vesting fully on May 16, 2025.

Precigen's President and CEO, Helen Sabzevari, reports the acquisition of 1,079,137 Restricted Stock Units (RSUs) that will vest on May 16, 2025.

Director Randal J. Kirk reports transactions involving Precigen, Inc. common stock and derivative securities, including acquisitions of stock and options, and disposal of restricted stock units.

Director Nancy Agee acquired shares and restricted stock units of Precigen, Inc. on March 13, 2025, in lieu of an annual retainer.

Director Vinita D. Gupta reports transactions involving Precigen, Inc. common stock and restricted stock units, including acquisitions in lieu of retainer and vesting of RSUs.

Director Fred Hassan reports acquiring and disposing of Precigen, Inc. common stock and restricted stock units (RSUs) on March 13 and 14, 2025.

Director James S. Turley reports acquisition and disposal of Precigen, Inc. common stock and restricted stock units.

Director Jeffrey Kindler reports transactions involving Precigen, Inc. common stock and restricted stock units, including acquisitions and disposals.

Director Steven Frank reports transactions involving Precigen, Inc. common stock and restricted stock units, including acquisitions, disposals, and vesting of RSUs.

Director Cesar L. Alvarez reports changes in beneficial ownership of Precigen, Inc. stock, including acquisitions of common stock and restricted stock units (RSUs), as well as disposal of common stock.

Precigen's Chief Commercial Officer, Phil Tennant, acquired 25,000 shares of common stock upon vesting of performance stock units and sold 9,441 shares to cover tax obligations.

Precigen's Chief Operating Officer, Rutul Shah, acquired 125,000 shares of common stock through the vesting of performance stock units and sold 47,151 shares to cover income tax obligations.